{
    "clinical_study": {
        "@rank": "30096", 
        "arm_group": [
            {
                "arm_group_label": "LBC", 
                "arm_group_type": "Active Comparator", 
                "description": "Cervical cancer screening by using liquid based cytology as a standard screening modality"
            }, 
            {
                "arm_group_label": "LBC plus HPV DNA testing", 
                "arm_group_type": "Experimental", 
                "description": "Cervical cancer screening by using liquid based cytology plus HPV DNA testing as an experimentally screening modality"
            }
        ], 
        "brief_summary": {
            "textblock": "The aim of this study is to assess efficacy of the screening with concurrent liquid-based\n      cytology and HPV DNA testing for the primary cervical cancer screening over 7 years."
        }, 
        "brief_title": "Randomized Controlled Trial of Co-testing Liquid-based Cytology ( LBC) and HPV DNA Testing for the Primary Cervical Cancer Screening", 
        "completion_date": {
            "#text": "March 2021", 
            "@type": "Anticipated"
        }, 
        "condition": "Cervical Cancer", 
        "condition_browse": {
            "mesh_term": "Uterine Cervical Neoplasms"
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          1. Women aged 30-64 years old\n\n          2. Participants provided written informed consent\n\n        Exclusion Criteria:\n\n        Women who\n\n          1. will receive planed HPV DNA testing by local governmental cervical cancer program\n             next six years\n\n          2. have had cervical invasive cancer before\n\n          3. have undergone cervical conization\n\n          4. have undergone hysterectomy\n\n          5. have had or have the cytological abnormalities and are under follow-up\n\n          6. are pregnant\n\n          7. are judged ineligible for this trial by physician"
            }, 
            "gender": "Female", 
            "healthy_volunteers": "Accepts Healthy Volunteers", 
            "maximum_age": "64 Years", 
            "minimum_age": "30 Years"
        }, 
        "enrollment": {
            "#text": "30000", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "July 4, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01895517", 
            "org_study_id": "TRIUC1312", 
            "secondary_id": "UMIN000010843"
        }, 
        "intervention": [
            {
                "arm_group_label": "LBC", 
                "description": "Cervical cancer screening by using liquid based cytology as a standard screening modality", 
                "intervention_name": "LBC", 
                "intervention_type": "Other"
            }, 
            {
                "arm_group_label": "LBC plus HPV DNA testing", 
                "description": "Cervical cancer screening by using liquid based cytology plus HPV DNA testing as an experimentally screening modality", 
                "intervention_name": "LBC plus HPV DNA testing", 
                "intervention_type": "Other"
            }
        ], 
        "is_fda_regulated": "No", 
        "lastchanged_date": "January 27, 2014", 
        "location": {
            "contact": {
                "email": "aoki@z7.keio.jp", 
                "last_name": "Daisuke Aoki, M.D., Ph.D.", 
                "phone": "+81-3-3353-1211"
            }, 
            "facility": {
                "address": {
                    "city": "Shinjuku", 
                    "country": "Japan", 
                    "state": "Tokyo", 
                    "zip": "160-8582"
                }, 
                "name": "School of Medicine, Keio University"
            }, 
            "investigator": {
                "last_name": "Daisuke Aoki, M.D., Ph.D.", 
                "role": "Principal Investigator"
            }, 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "Japan"
        }, 
        "number_of_arms": "2", 
        "official_title": "Randomized Controlled Trial to Evaluate the Efficacy of Concurrent Liquid-based Cytology ( LBC) and HPV DNA Testing Versus LBC Alone for the Primary Cervical Cancer Screening", 
        "overall_contact": {
            "email": "aoki@z7.keio.jp", 
            "last_name": "Daisuke Aoki, M.D., Ph.D.", 
            "phone": "+81-3-3353-1211"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "Japan: Institutional Review Board", 
            "has_dmc": "No"
        }, 
        "phase": "Phase 4", 
        "primary_completion_date": {
            "#text": "March 2020", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "measure": "The incidence of cervical intraepithelial neoplasia(CIN)3 or worse during the whole period", 
            "safety_issue": "No", 
            "time_frame": "6 years"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01895517"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": [
            {
                "measure": "The incidence of CIN3 or worse at baseline, and two years, four years, and six years post baseline", 
                "safety_issue": "No", 
                "time_frame": "2 years, 4 years, 6 years"
            }, 
            {
                "measure": "The incidence of CIN2 or worse at baseline, and two years, four years, and six years post baseline", 
                "safety_issue": "No", 
                "time_frame": "2 years, 4 years, 6 years"
            }, 
            {
                "measure": "The incidence of CIN1 or worse at baseline, and two years, four years, and six years post baseline", 
                "safety_issue": "No", 
                "time_frame": "2 years, 4 years, 6 years"
            }, 
            {
                "measure": "The incidence of invasive cancer at baseline, and two years, four years, and six years post baseline", 
                "safety_issue": "No", 
                "time_frame": "2 years, 4 years, 6 years"
            }, 
            {
                "measure": "The number of cervical cytology performance", 
                "safety_issue": "No", 
                "time_frame": "6 years"
            }, 
            {
                "measure": "The number of colposcopy and biopsy performance", 
                "safety_issue": "No", 
                "time_frame": "6 years"
            }
        ], 
        "source": "Translational Research Informatics Center, Kobe, Hyogo, Japan", 
        "sponsors": {
            "collaborator": [
                {
                    "agency": "Keio University", 
                    "agency_class": "Other"
                }, 
                {
                    "agency": "Jikei University School of Medicine", 
                    "agency_class": "Other"
                }
            ], 
            "lead_sponsor": {
                "agency": "Translational Research Informatics Center, Kobe, Hyogo, Japan", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "June 2013", 
        "study_design": "Allocation: Randomized, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Screening", 
        "study_type": "Interventional", 
        "verification_date": "January 2014"
    }
}